Sweetness and bitterness taste of meals per se does not mediate gastric emptying in humans.
In cell line and animal models, sweet and bitter tastants induce secretion of signaling peptides (e.g., glucagon-like peptide-1 and cholecystokinin) and slow gastric emptying (GE). Whether human GE and appetite responses are regulated by the sweetness or bitterness per se of ingested food is, however, unknown. We aimed to determine whether intragastric infusion of "equisweet" (Study A) or "equibitter" (Study B) solutions slow GE to the same extent, and whether a glucose solution made sweeter by the addition of saccharin will slow GE more potently than glucose alone. Healthy nonobese subjects were studied in a single-blind, randomized fashion. Subjects received 500-ml intragastric infusions of predetermined equisweet solutions of glucose (560 mosmol/kgH(2)O), fructose (290 mosmol/kgH(2)O), aspartame (200 mg), and saccharin (50 mg); twice as sweet glucose + saccharin, water (volumetric control) (Study A); or equibitter solutions of quinine (0.198 mM), naringin (1 mM), or water (Study B). GE was evaluated using a [(13)C]acetate breath test, and hunger and fullness were scored using visual analog scales. In Study A, equisweet solutions did not empty similarly. Fructose, aspartame, and saccharin did not slow GE compared with water, but glucose did (P < 0.05). There was no additional effect of the sweeter glucose + saccharin solution (P > 0.05, compared with glucose alone). In Study B, neither bitter tastant slowed GE compared with water. None of the solutions modulated perceptions of hunger or fullness. We conclude that, in humans, the presence of sweetness and bitterness taste per se in ingested solutions does not appear to signal to influence GE or appetite perceptions.
Little
Tanya J
TJ
Univ. of Manchester, Section of Gastrointestinal Sciences, Clinical Sciences Bldg., Salford Royal NHS Foundation Trust, Stott Lane, Salford, United Kingdom, M6 8HD. tanya.little@adelaide.edu.au
Gupta
Nili
N
Case
R Maynard
RM
Thompson
David G
DG
McLaughlin
John T
JT
D000085:Acetates / Q000378:metabolism; D000328:Adult; D001069:Appetite Regulation / Q000187:drug effects; D001218:Aspartame / Q000008:administration & dosage; D001944:Breath Tests; D002247:Carbon Isotopes; D004305:Dose-Response Relationship, Drug; D004435:Eating; D005260:Female; D044950:Flavanones / Q000008:administration & dosage; D005632:Fructose / Q000008:administration & dosage; D005746:Gastric Emptying / Q000187:drug effects; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D006815:Hunger; D007441:Intubation, Gastrointestinal; D008297:Male; D008875:Middle Aged; D010465:Perception; D011803:Quinine / Q000008:administration & dosage; D012439:Saccharin / Q000008:administration & dosage; D012527:Satiation; D016037:Single-Blind Method; D013549:Sweetening Agents / Q000008:administration & dosage; D013649:Taste / Q000187:drug effects; D013997:Time Factors; D055815:Young Adult
D000085:Acetates; D002247:Carbon Isotopes; D044950:Flavanones; D013549:Sweetening Agents; D005632:Fructose; D011803:Quinine; D012439:Saccharin; D005947:Glucose; C005274:naringin; D001218:Aspartame